Inhibition of squamous cell carcinoma angiogenesis by direct interaction of retinoic acid with endothelial cells

Laboratory Investigation

Volumn 74, Issue 2, 1996, Pages 476-483

  Lingen, Mark W ^a,b   Polverini, Peter J ^c   Bouck, Noël P ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; RETINOIC ACID;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL GROWTH; CELL MIGRATION; ENDOTHELIUM CELL; FEMALE; HUMAN; KERATINOCYTE; MITOGENESIS; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; RAT; SQUAMOUS CELL CARCINOMA;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CATTLE; CELL DIVISION; CELL LINE; CELL MOVEMENT; CORNEA; CULTURE MEDIA, CONDITIONED; DRUG IMPLANTS; ENDOTHELIUM, VASCULAR; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; TRETINOIN;

EID: 0030069882     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Arensman RM and Stolar CH (1979). Vitamin A effect on tumor angiogenesis. J Pediatr Surg 14:809-813.
2. Bicknell R (1993). Heterogeneity of the endothelial cell. Behring Inst Mitt 92:1-7.
3. Braunhut SJ and Palomares M (1991). Modulation of endothelial cell shape and growth by retinoids. Microvasc Res 41:47-62.
4. Braunhut SJ and Moses MA (1994). Retinoids modulate endothelial cell proliferation of matrix-degrading proteases and tissue inhibitors of metalloproteinases (TIMP). J Biol Chem 269:13472-13479.
5. Castle VP, Ou X, O'Shea S, Dixit VM (1992). Induction of thrombospondin 1 by retinoic acid is important during differentiation of neuroblastoma cells. J Clin Invest 90:1857-1863.
6. Folkman J. Tumor angiogenesis. In: The molecular basis of cancer. J Mendelsohn. Howley PM, Israel MA, Liotta LA, editors. Philadelphia: W. B. Saunders, 206-232.
7. Folkman J and Shing Y (1992). Angiogenesis. J Biol Chem 16:10931-10934.
8. Frickel F (1984). Chemistry and physical properties of retinoids. In: The retinoids, Vol. 1. Sporn MB, Roberts AB, Goodman DS, editors. Orlando: Academic Press, 8-145.
9. Good DJ, Polverini PJ, Rastinejad F, LeBeau MM, Lemons RS, Frazier WA, and Bouck NP (1990). A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc Natl Acad Sci (USA) 87:6624-6628.
10. Holmgren L, O'Reilly MS, and Folkman J (1995). Dormancy of micrometastases-balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Med 1:149-153.
11. Hong KW, Lippman SM, Itri LM, Karp DD, Lee JS, Byers RM, Schantz SP, Kramer AM, Lotan R, Peters LJ, Dimery IW, Brown BW, and Goepfert H (1990). Prevention of second primary tumors with isotretinoin in squamous cell carcinoma of the head and neck. N Engl J Med 323:795-801.
12. Ingber D and Folkman J (1988). Inhibition of angiogenesis through modulation of collagen metabolism. Lab Invest 59: 44-51.
13. Johnson MD, Kim HC, Chesler L, Tsao-Wu G, Bouck N, and Polverini PJ (1994). Inhbition of angiogenesis by tissue inhibitor of metalloproteinase. J Cell Physiol 160:194-202.
14. Kojima S and Rifkin DB (1993). Mechanism of retinoid-induced activation of latent transforming growth factor-B in bovine endothelial cells. J Cell Physiol 155:323-332.
15. Lingen MW, Polverini PJ, and Bouck NP (in press, 1996). Retinoic acid induces cells cultured from oral squamous cell carcinomas to become antiangiogenic. Am J Pathol.
16. Lippman SM, Batsakis JG, Toth BB, Weber RS, Lee JJ, Martin JW, Hays GL, Goepfert H, and Hong KW (1993). Comparison of low-dose isotretinoin with beta carotene to prevent carcinogenesis. N Engl J Med 328:15-20.
17. Majewski S, Szmurlo A, Marczak M, Jablonska S, and Bollag W (1993). Inhibition of tumor cell-induced angiogenesis by retinoids, 1-25-dihydroxyvitamin D3 and their combination. Cancer Lett 75:35-39.
18. Majewski S, Szmurlo A, Marczak M, Jablonska S, and Bollag W (1994). Synergistic effect of retinoids and interferon alpha on tumor-induced angiogenesis: Anti-angiogenic effect on hpv-harboring tumor-cell lines. Int J Cancer 57:81-85.
19. Majewski S, Marczak M, Szmurlo A, Jablonska S, and Bollag W (1995). Retinoids, interferon alpha, 1,25-dihydroxyvitamin D3 and their combination inhibit angiogenesis induced by non-hpv-harboring tumor cell lines. RAR alpha mediates the antiangiogenic effects of retinoids. Cancer Lett 89:117-124.
20. Mantovani A (1994). Tumor-associated macrophages in neoplastic disease: A paradigm for the in vivo function of cytokines. Lab Invest 71:5-16.
21. Napoli JL, Pramanik BC, Williams JB, Dawson MI, and Hobbs PD (1985). Quantification of retinoic acid by gas-liquid chromatography-mass spectrometry: Total versus all-trans-retinoic acid in human plasma. J Lipid Res 26:387-392.
22. Oikawa T, Nakamura O, Shudo K, Hiragun A, and Iwaguchi T (1989). A highly potent antiangiogenic activity of retinoids. Cancer Lett 48:157-162.
23. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, and Folkman J (1995). Angiostatin: A novel inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79:315-328.
24. Pepper MS, Vassalli JD, Orci L, and Montesan R (1993). Biphasic effect of transforming growth factor-B1 on in vitro angiogenesis. Exp Cell Res 204:356-363.
25. Pepper MS, Vassalli JD, Wilks JW, Schweigerer L, Orci L, Montesano R (1994). Modulation of bovine microvascular endothelial cell proteolytic properties by inhibitors of angiogenesis. J Cell Biochem 55:419-434.
26. Polverini PJ, Bouck NP, and Rastinejad F (1991). Assay and purification of naturally occurring inhibitor of angiogenesis. Methods Enzymol 198:440-450.
27. Rastinejad F, Polverini PJ, and Bouck NP (1989). Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell 56:345-355.
28. Rheinwald JG, Beckett MA (1981). Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultured from human squamous cell carcinomas. Cancer Res 41: 1657-1663.
29. Rudnicka L, Marczak M, Szmurlo A, Makiela B, Skiendzielewska A, Skopinska M, Majewski S, and Jablonska S (1991). Acitretin decreases tumor cell-induced angiogenesis. Skin Pharmacol 4:150-153.
30. Smith MA, Parkinson DR, Cheson BD, Friedman MA (1992). Retinoids in cancer therapy. J Clin Oncol 10:839-864.
31. Spencer-Green G (1994). Retinoic acid effects on endothelial cell function: Interaction with interleukin 1. Clin Immunol Immunopathol 72:53-61.
32. Stetler-Stevenson WG and Ray RM (1994). The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis. Eur Respir J 7:2062-2072.
33. Tolsma SS, Volpert OV, Good DJ, Frazier WA, Polverini PJ, and Bouck N (1993). Peptides derived from two separate domains of thrombospondin-1 have anti-angiogenic activity. J Cell Biol 122:497-511.
34. Varani J, Astrom A, Griffiths CE, and Voorhees JJ (1991). Induction of proliferation of growth-inhibited keratinocytes and fibroblasts in monolayer culture by sodium lauryl sulfate: Comparison with all-trans retinoic acid. J Invest Dermatol 97:917-921.